Free press releases distribution network?

Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Label-Free Technology is a High Potential Market with Myriad Unexplored Applications Finds Frost & Sullivan - Label-free Technology is still poorly understood, but has proven to have great potential for its small but expanding end-user base - DrugDiscovery.Frost.com
Label-Free Technology is a High Potential Market with Myriad Unexplored Applications Finds Frost & Sullivan

 

PRZOOM - /newswire/ - London, United Kingdom, 2012/07/02 - Label-free Technology is still poorly understood, but has proven to have great potential for its small but expanding end-user base - DrugDiscovery.Frost.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The inherent advantages of label-free technology is a significant factor in driving its adoption. The promise of reducing drug failure caused by toxicity is another key factor likely to boost the uptake of label-free technology.

New analysis from Frost & Sullivan (drugdiscovery.frost.com), Western European Market for Label Free Detection (LFD) Systems, finds that the market earned revenues of $60.9 million in 2010 and estimates this to reach $160.9 million in 2017 at a compound annual growth rate (CAGR) of 14.9 per cent from 2010-2017. The research covers key segments including biochemical assays and cell-based assays.

"The key advantage of label-free technologies is that it is true to its word: it is "label-free" as it requires no labelling or reporter molecules," notes Frost & Sullivan Programme Manager Ranjith Gopinathan. "Labels are known for their altering effect on molecules under study which, in turn, alters its binding or physicochemical properties."

The absence of labels also means lesser interference from compound autofluorescence and colour quenching, therefore leading to fewer false positives and negatives. It is also devoid of problems arising from secondary detection of auxiliary reagents.

"By virtue of its direct detection capabilities, label-free technologies could enable the use of natural ligands and substrates that is currently not possible with label-based detection assays," adds Gopinathan. "Avoidance of radioactive labels is an attractive factor for label-free technologies as this means better lab safety and cost savings from evasion of radioactive waste disposable procedures."

Of the many reasons for escalating clinical development costs, drug failure caused by toxicity is a chronic and growing problem in drug development. The problem of toxicity holds the promise of being successfully addressed with new, discovery-stage tools of which label-free technology is a key part.

While these are promising trends, consolidations in the pharmaceutical industry will negatively impact the growth of the life science research market and, by extension, of label-free detection systems.

"The large number of consolidations in the pharmaceutical industry is a harsh reality for all life science research tools providers," explains Gopinathan. "Consolidation significantly shrinks the addressable end-user pool as research facilities start to share instrumentation and resources. Sometimes after a merger or acquisition, companies segregate certain specialised kinds of work to certain research facilities, and so only those facilities will be equipped with the required equipment."

A diversification into service offerings will be key to sustaining market expansion. Being still a black box technology, companies need to offer custom assay development services that will help in the adoption of their technology.

"This, in the long-term, can lead to the upsell of a service customer into a product customer," concludes Gopinathan. "Also having more than one avenue of revenue will ensure more constant revenue generation."

If you are interested in more information on this study, please send an email with your contact details to Janique Morvan, Corporate Communications, at janique.morvan[.]frost.com.

Western European Market for Label Free Detection (LFD) Systems is part of the Drug Discovery Technologies Growth Partnership Services programme, which also includes research in the following markets: European Molecular Diagnostics Market, Strategic Analysis of the European Stem Cell Research Tools Market and The Emerging European Molecular POC Testing Markets. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

About Frost & Sullivan
Frost & Sullivan (frost.com), the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us: Start the discussion | Join Us: Join our community | Subscribe: Newsletter on "the next big thing" | Register: Gain access to visionary innovation.

Western European Market for Label Free Detection (LFD) Systems / M419-55

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Label-Free Technology is a High Potential Market with Myriad Unexplored Applications Finds Frost & Sullivan

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Frost & Sullivan |
Contact: Janique Morvan 
+33(0)1 42 81 20 37 / +33(0)6 79 22 41 42 (mobile) janique.morvan[.]frost.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Frost & Sullivan / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  BizJobs.com

Visit  JobsWare.com

Visit  Triggr & Bloom







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today